The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Investing.com -- Novo Nordisk (NYSE: NVO) shares climbed 5.4% Friday after the U.S. Food and Drug Administration accepted the ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...

More than a billion people now have obesity worldwide, according to the WHO, and around 70% of them live in low and ...

First, he landed his role in "Modern Family," a critically acclaimed ABC sitcom that went on for 11 seasons and catapulted ...

NewEdge Wealth CEO Rob Sechan owns it and breaks it down, while the Investment Committee drops their latest picks.

Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an ...

Young US women with breast cancer are not dying from the disease as often as a decade ago, researchers reported at the ...

On this week’s episode of the Readout LOUD, we review President Trump’s first 100 days, the return of biotech M&A, strong ...

Navigating ineffective weight management treatment is a sensitive process that requires acknowledgement of bias from both ...

One person can make a difference. Lilly Ledbetter, who pushed forward legislation that makes equal pay for men and women the ...